+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genocea Biosciences - logo

Genocea Biosciences is a biopharmaceutical company that develops novel vaccines and immunotherapies to treat infectious diseases. The company uses its proprietary discovery platform AnTigen Lead Acquisition System to design vaccines and immunotherapies that act through T cell immune responses. Its lead product candidate is GEN-003, a therapeutic vaccine or immunotherapy that is in Phase 2 trial for the treatment of genital herpes infections. Founded in 2006, it is headquartered in Cambridge, Massachusetts.

From
Merkel Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Novel Vaccine Delivery Devices Market, 2019-2030 - Product Thumbnail Image

Novel Vaccine Delivery Devices Market, 2019-2030

  • Report
  • November 2019
  • 403 Pages
  • Global
From
From
From
From
From
From
From
Cancer Vaccines Market, Pipeline Analysis Report 2020 - Product Thumbnail Image

Cancer Vaccines Market, Pipeline Analysis Report 2020

  • Report
  • June 2020
  • 115 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
Loading Indicator